ArticleFrontiers in medicine2021

LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis.

Qing-Fang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.